Clinical Trials Logo

Pediatric Disorder clinical trials

View clinical trials related to Pediatric Disorder.

Filter by:

NCT ID: NCT05762835 Recruiting - Pediatric Disorder Clinical Trials

Neonatal Intensive Care Unit Virtual Family-Centered Rounds

Start date: March 13, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the impact of virtual family-centered rounds in the neonatal intensive care unit on parental and neonatal outcomes.

NCT ID: NCT05759767 Active, not recruiting - Pediatric Disorder Clinical Trials

The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the clinical efficacy and safety of MET after ESWL in pediatric urolithiasis.

NCT ID: NCT05749419 Recruiting - Clinical trials for Congenital Disorders

Vaccinations and People With Disabilities

Start date: July 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about vaccinations hesitancy, delay or avoidance in children with chronic diseases, congenital anomalies or disabilities. The main questions it aims to answer are: • Attitudes of caregivers towards vaccinating their children, obstacles that postpone vaccinations, and the status of vaccinations of these children. Participants will fill out questionnaires and some will be included in focused groups for the qualitative part of the study. Researchers will compare the vaccinations status of the research group to their siblings' status as well as the published national records of vaccination compliance.

NCT ID: NCT05748314 Recruiting - Rare Diseases Clinical Trials

Marfan Syndrome and Quality of Life of Pediatric Patients

MarfanPed
Start date: January 9, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about the impact of Marfan syndrome (MFS) in paediatric affected subjects. the main questions it aims to answer are: - The assessment of quality of life in MFS Italian patients; - The impact of phenotypic manifestations on self-image and self-management skills; - Stratify patients according to the need of psychological support. Participants will take part in the study by completing four self-report questionnaires.

NCT ID: NCT05593900 Completed - Pediatric Disorder Clinical Trials

Nurse-To-Family Telehealth

Start date: January 3, 2023
Phase: N/A
Study type: Interventional

This study will be a pilot test of using telehealth to allow nurses to connect with parents/guardians of pediatric patients who are being transferred between hospitals.

NCT ID: NCT05590884 Recruiting - Clinical trials for Central Nervous System Diseases

Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age

Start date: September 21, 2022
Phase: Phase 2
Study type: Interventional

This Phase II open-label, uncontrolled, multicenter trial is designed to investigate the pharmacokinetic (PK) profile of gadopiclenol in plasma, in pediatric patients aged up to 23 months inclusive (term neonates or preterm infants after the neonatal period), using a population PK approach. Primary objective is to evaluate the PK profile of gadopiclenol in plasma following single intravenous injection of 0.05 mmol/kg body weight (BW) in pediatric population aged up to 23 months (inclusive) scheduled for a contrast-enhanced MRI examination of any body region including central nervous system (CNS).

NCT ID: NCT05539456 Enrolling by invitation - Quality of Life Clinical Trials

Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old

Start date: September 1, 2022
Phase:
Study type: Observational

The aim of the investigator's study was to investigate translating the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old and using it in clinics reliably and validity with a Turkish version of the PedsQL Generic Core (Pediatric Quality of Life Questionnare) in children with Spinal Muscular Atrophy in Turkey

NCT ID: NCT05354622 Recruiting - Movement Disorders Clinical Trials

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

Start date: April 25, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of the HSP Sequencing Initiative is to better understand the role of genetics in hereditary spastic paraplegia (HSP) and related disorders. The HSPs are a group of more than 80 inherited neurological diseases that share the common feature of progressive spasticity. Collectively, the HSPs present the most common cause of inherited spasticity and associated disability, with a combined prevalence of 2-5 cases per 100,000 individuals worldwide. In childhood-onset forms, initial symptoms are often non-specific and many children may not receive a diagnosis until progressive features are recognized, often leading to a significant diagnostic delay. Genetic testing in children with spastic paraplegia is not yet standard practice. In this study, the investigators hope to identify genetic factors related to HSP. By identifying different genetic factors, the investigators hope that over time we can develop better treatments for sub-categories of HSP based on cause.

NCT ID: NCT05350904 Recruiting - Pediatric Disorder Clinical Trials

Hybrid Telehealth in Pediatric Physical Therapy

Start date: May 15, 2022
Phase: N/A
Study type: Interventional

The purposes of this study are to compare the impact of a hybrid of telehealth and in-person physical therapy services to in-person services alone on the in-home functional skills of children with moderate to severe disability. This is a mixed methods study.

NCT ID: NCT05331898 Completed - Pediatric Disorder Clinical Trials

Rational Drug Use Education Parental Attitudes

Start date: June 19, 2020
Phase: N/A
Study type: Interventional

The study aims to examine the effect of rational drug use education given to parents on parental attitudes. The pretest-posttest randomized controlled experimental study was carried out in Erzurum between June 2020 and September 2021. The study's population comprised parents with children aged 0 to 12 who were registered at an Erzurum FHC. The study sample consisted of 100 parents who came to the FHC on the specified dates and matched research criteria. "Parent Introductory Information Form", "Parental Attitude Scale for Rational Drug Use (PASRDU)" and "Rational Drug Use Education" were used to collect research data.